At the One Health Trust, our team has conducted several studies on antibiotic consumption in diverse contexts. Tracking antibiotic consumption globally and regionally is crucial for combating antimicrobial resistance (AMR), which poses a significant threat to health worldwide. By monitoring antibiotic use, we can identify trends and areas requiring diagnostic or treatment access, prevent overuse or misuse of antibiotics, and ensure effective treatment protocols.
Data on antibiotic consumption informs healthcare organizations, units, and policymakers how to implement targeted strategies, such as promoting responsible prescribing practices and ensuring equitable access to effective antibiotics. In addition, understanding consumption patterns across different contexts – such as socioeconomic, geographic, and healthcare settings, and during particular disease outbreaks – allows for tailored interventions. Monitoring antibiotic use is vital to preserving the effectiveness of these medications, safeguarding public health, and reducing AMR’s impact worldwide.
Kumar, C. K., Gleason, A. C., Parameswaran, G. G., Summan, A., Klein, E., Laxminarayan, R., & Nandi, A. (2024). Routine immunization against Streptococcus pneumoniae and Haemophilus influenzae type B and antibiotic consumption in India: a dynamic modeling analysis. The Lancet Regional Health – Southeast Asia, 31, 100498. Available here.
- Klein, E. Y., Impalli, I., Poleon, S., Denoel, P., Cipriano, M., Van Boeckel, T. P., Pecetta, S., Bloom, D. E., & Nandi, A. (2024). Global trends in antibiotic consumption during 2016–2023 and future projections through 2030. Proceedings of the National Academy of Sciences, 121(49). Available here.
- Allel, K., Day, L., Hamilton, A., Lin, L., Furuya-Kanamori, L., Moore, C. E., Van Boeckel, T., Laxminarayan, R., & Yakob, L. (2023). Global antimicrobial-resistance drivers: an ecological country-level study at the human–animal interface. The Lancet Planetary Health, 7(4), e291–e303. Available here.
- Hamilton, A., Poleon, S., Cherian, J., Cosgrove, S., Laxminarayan, R., & Klein, E. (2023). COVID-19 and outpatient antibiotic prescriptions in the United States: A County-Level analysis. Open Forum Infectious Diseases, 10(3). Available here.
- Hamilton, A., Poleon, S., Cherian, J., Cosgrove, S. E., Laxminarayan, R., & Klein, E. Y. (2022). 1788. COVID-19 and antibiotic prescriptions in the United States: a county-level analysis. Open Forum Infectious Diseases, 9(Supplement_2). Available here.
- Nandi, A., Pecetta, S., & Bloom, D. E. (2023). Global antibiotic use during the COVID-19 pandemic: analysis of pharma ceutical sales data from 71 countries, 2020–2022. EClinicalMedicine, 57, 101848. Available here.
- Klein, E. Y., Milkowska-Shibata, M., Tseng, K. K., Sharland, M., Gandra, S., Pulcini, C., & Laxminarayan, R. (2020). Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data. The Lancet Infectious Diseases, 21(1), 107–115. Available here.
- Klein, E. Y., Schueller, E., Tseng, K. K., Morgan, D. J., Laxminarayan, R., & Nandi, A. (2020). The impact of influenza vaccination on antibiotic use in the United States, 2010–2017. Open Forum Infectious Diseases, 7(7). Available here.
- Lewnard, J. A., Lo, N. C., Arinaminpathy, N., Frost, I., & Laxminarayan, R. (2020). Childhood vaccines and antibiotic use in low- and middle-income countries. Nature, 581(7806), 94–99. Available here.
